Search Results for 'Disruptive Technology Innovation Fund'

A groundbreaking clinical trial led by researchers at the University of Galway is set to transform the treatment of a chronic and debilitating vein condition. Forty patients with venous leg ulcers (VLUs) are being enrolled in the trial in Ireland, which is coordinated through the University’s Institute for Clinical Trials, enabling clinicians to monitor and direct treatment remotely in real time.

Parkmore-based VERSONO® Medical Ltd has begun enrolling patients in the FREEFLOW pivotal study for its FastWire System. FastWire is a truly disruptive technology designed to quickly access previously untreatable complex blockages in arteries, increasing success rates and reducing risk of amputations via endovascular techniques.

Parkmore-based VERSONO® Medical Ltd has begun enrolling patients in the FREEFLOW pivotal study for its FastWire System. FastWire is a truly disruptive technology designed to quickly access previously untreatable complex blockages in arteries, increasing success rates and reducing risk of amputations via endovascular techniques.

Athlone was one of four towns selected by CeADAR, Ireland’s centre for Applied AI, as a case study in the use of artificial intelligence and satellite technology to develop an early warning system for communities at risk of severe flooding.

MedTech firm FeelTect is set to expand its workforce at the company's headquarters in Spiddal, Co. Galway, after securing €1.5m in new investment.